<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00434863</url>
  </required_header>
  <id_info>
    <org_study_id>CR-015-LK/2005</org_study_id>
    <nct_id>NCT00434863</nct_id>
  </id_info>
  <brief_title>Comparative Study of the Effect of Dysport and Botox</brief_title>
  <official_title>A Comparative Randomized Double-Blinded Study of the Effect of Dysport and Botox on Forehead Wrinkles and EMG Activity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laserklinik Karlsruhe</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laserklinik Karlsruhe</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the effect of Dysport and Botox on forehead wrinkles and
      EMG activity.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2005</start_date>
  <completion_date>March 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>EMG Muscular Activity at baseline and 0.5, 1, 2, 4, 8 and 10 weeks after injection, followed by weekly examinations for a total observation period of 20 weeks</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Frown Wrinkle Severity (photographs and questionnaire) at baseline and 0.5, 1, 2, 4, 8 and 10 weeks after injection, followed by weekly examinations for a total observation period of 20 weeks</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Side Effects upon completion of the study (20 weeks after injection)</measure>
  </secondary_outcome>
  <enrollment>24</enrollment>
  <condition>Aging</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>botulinum toxin type A</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age between 30 and 70 years

          -  moderate to severe hyperfunctional forehead wrinkles at maximum contraction and at
             rest

        Exclusion Criteria:

          -  application of botulinum toxin products for a period of 12 months prior to the study

          -  any significant health disturbances

          -  facial nerve palsy, and any facial conditions that could confound safety or efficacy
             results

          -  pregnancy and breast-feeding

          -  neuromuscular diseases

          -  drugs interfering with neuromuscular function (e.g. aminoglycosides)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Syrus Karsai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Laserklinik Karlsruhe</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Laserklinik Karlsruhe</name>
      <address>
        <city>Karlsruhe</city>
        <state>BW</state>
        <zip>76133</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2007</study_first_submitted>
  <study_first_submitted_qc>February 12, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2007</study_first_posted>
  <last_update_submitted>February 12, 2007</last_update_submitted>
  <last_update_submitted_qc>February 12, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 13, 2007</last_update_posted>
  <keyword>botulinum toxin type A</keyword>
  <keyword>Dysport®</keyword>
  <keyword>Botox®</keyword>
  <keyword>hyperfunctional forehead lines</keyword>
  <keyword>randomized controlled trial</keyword>
  <keyword>double-blinded trial</keyword>
  <keyword>electromyogram (EMG)</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>onabotulinumtoxinA</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

